Kura Oncology (KURA) Treasury Shares (2014 - 2026)

Kura Oncology (KURA) reported Treasury Shares of $436667.0 for Q1 2026, little changed quarter-over-quarter from $436667.0 in Q4 2025.

Kura Oncology (KURA) Treasury Shares (2014 - 2026) Analysis & Trends

Kura Oncology (KURA) has 6 years of Treasury Shares data on file, last reported at $436667.0 in Q1 2026.

Treasury Shares for Q1 2026 came in at $436667.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $436667.0 (changed N/A YoY), and the FY2025 annual result was $436667.0, changed N/A from the prior year.
Treasury Shares steadied at $436667.0 in Q1 2026 per KURA's latest filing, from $436667.0 in the prior quarter.
Over five years, Treasury Shares peaked at $775534.0 in Q3 2025 and troughed at $436667.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	1.48 Mn
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	700,000.00
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Kura Oncology	883.44 Mn	883.44 Mn	18.00 Mn	436,667.00

Download Data